AngioSoma, Inc.

Common Stock SEC Reporting - Current
OTC Pink Current Information
Verified Company Profile 5/16/2017
Contact Info
  • 2500 Wilcrest Drive
  • 3rd Floor
  • Houston, TX 77042

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001502152
Fiscal Year End 9/30
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2010
Employees 1 a/o May 15, 2017
Company Officers/Contacts
Alex K. Blankenship President, CEO
Company Directors
Alex K. Blankenship Chairman
David P. Summers, PhD, MBA, F Chairman Emeritus
Company Notes
  • Formerly=First Titan Corp. until 6-2016
Service Providers
Accounting/Auditing Firm
4100 North Sam Houston Pkwy W
Suite 200-B
Houston, TX, 77086
United States

Legal Counsel
Sonfield & Sonfield, Attorneys at Law
2500 Wilcrest Dr
Suite 300
Houston, TX, 77042
United States

Investor Relations Firm
Not Available
SOAN Security Details
Share Structure
Market Value1 $3,902,986 a/o Sep 20, 2017
Authorized Shares 480,000,000 a/o May 10, 2017
Outstanding Shares 41,084,067 a/o May 10, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 12,488,734 a/o May 10, 2017
Par Value Not Available
Shareholders of Record 5 a/o Mar 29, 2017
Short Selling Data
Short Interest 715 (0%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security